This research examines the adoption of blockchain technology in pharmaceutical supply chains, focusing on the barriers that prevent most initiatives from moving beyond the pilot stage. Drawing on expert perspectives and the Technology Acceptance Model, it identifies organizational, regulatory, and cultural challenges as well as strategies to overcome them.
About the authors
Raya Al-Halaseh and Niklas van Riesen research blockchain adoption in pharmaceutical supply chains, focusing on implementation barriers and strategies for scalable, business-viable traceability systems.
This research examines the adoption of blockchain technology in pharmaceutical supply chains, focusing on the barriers that prevent most initiatives from moving beyond the pilot stage. Drawing on expert perspectives and the Technology Acceptance Model, it identifies organizational, regulatory, and cultural challenges as well as strategies to overcome them.
Raya Al-Halaseh
Blockchain in Pharmaceutical Supply Chains Supply Chain Transparency Blockchain Adoption Barriers Pharmaceutical Supply Chains Counterfeit Drug Pharmaceutical Traceability Systems